be a potential market in the future. For Medical Devices; There is still intense competition in both domestic and foreign markets. Market leaders use price strategies to gain market share. But the
Company has been awarded ISO 13485, the Quality Management System for Medical Device Industry which is an important tool for competition and maintaining the product’s market share), the Company can maintain
increased when comparing with cash or equate with cash by 34 MB and increased 13 MB of account receivable and inventory stocks and decreased 9 MB and decreased of other debtor from the nullification of shares
decreased when comparing with cash or equate with cash by 32 MB and increased 6 MB of account receivable and increased of the inventory stocks by 15 MB and decreased of other debtor from the nullification of
and increased 6 MB of account receivable and increased of the inventory stocks by 15 MB and decreased of other debtor from the nullification of shares agreement between UBIS and RF Vision Co.,Ltd by 320
more short term loan of 299.49 Million Baht, trade receivable and other debtor of 282.30 Million Baht (more external trade account receivable of 320.49 Million Baht thus decline in accrued income of
share- holders (through what is known as 'tunnelling' 3 ), or misrepresenting an individual company's financial statements (of particular concern where the company is under pressure to meet expectations
(Translation) Securities and Exchange Act B.E. 2535 (As Amended) _________________ BHUMIBOL ADULYADEJ, REX., Given on the 12th day of March B.E. 2535; Being the 47th Year of the Present Reign. His Majesty King Bhumibol Adulyadej is graciously pleased to proclaim that: Whereas it is expedient to enact a law on the securities and exchange; Be it, therefore, enacted by His Majesty the King, by and with the advice and consent of the National Legislative Assembly functioning as both Houses of Parliam...
) EBIT 145.81 12.74 149.40 13.67 (3.59) (2.40) NP 115.58 10.09 116.50 10.66 (0.92) (0.79) EPS (Baht per Share) * 0.12 - 0.12 - - - Weighted Average Number of Ordinary Shares (Million Shares) * 947.96
74.67 57.77 8.23 GP 251.48 24.86 238.28 25.33 13.20 5.54 EBITDA 159.88 15.81 159.88 17.00 - - EBIT 100.80 9.97 98.15 10.44 2.65 2.70 NP 79.64 7.87 76.71 8.16 2.93 3.82 EPS (Baht per Share) * 0.08 0.08